Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-Risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is predictive of therapeutic response.

For high-risk prostate cancer, standard treatment options include radical prostatectomy (RP) or radiation therapy plus androgen-deprivation therapy (ADT). Despite definitive therapy, many patients will have disease recurrence.